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Aim. Surgical trauma and associated complications are frequently related to physiological stress during colectomy. This study
evaluated the response of adiponectin, resistin, and circulating soluble receptor for advanced glycation end products (sRAGE) in
colectomy patients with or without an enhanced recovery protocol. Method. Serum samples were collected from 44 colectomy
patients at 3 timframes. The surgical procedures were laparoscopic (LAP), hand-assisted laparoscopic (HALS), or open colectomy
(OPEN).Adiponectin, resistin, andsRAGE levelswere determined by ELISA.Repeated measuresANOVA wasappliedandP values
<0.05wereconsideredsigniﬁcant.Results.Atotalof132(44×3)serawereusedforanalysis.Levelsofadiponectinwassigniﬁcantly
decreased between PREOP and POD3 (P<0.001). Conversely, concentrations of resistin signiﬁcantly increased from PREOP to
POD1 and returned to baseline value by POD3 (P<0.001). Serum sRAGE levels were signiﬁcantly higher in LAP in comparison
with HALS (P = 0.004) and OPEN (P<0.001). sRAGE levels were signiﬁcantly higher in sera of patients that underwent ERP
(P<0.001). Conclusions. Serum adiponectin, resistin, and sRAGE have the potential to develop into a panel of stress markers.
Higher sRAGE levels in sera of LAP and ERP patients may be indicative of a protective and syngeristic role for colectomy recovery.
1.Introduction
Perioperative morbidity is particularly frequent with colec-
tomy and results in additional ﬁnancial burden for the pa-
tients as well as the health care systems. Colectomy is also
associated with signiﬁcant physiological stress as a result of
the surgical procedure itself, which may impact the risk of
complications. Traditionally, the physiological stress in re-
sponse tosurgery has beenmeasured in various ways, such as
invasiveness of procedure, length of procedure, and intraop-
erativebloodloss.Hemodynamic changes, peripheralinsulin
resistance, and the resultant hyperglycemia are also well-
known components of surgical stress. However, it remains
a challenge to elucidate the speciﬁcs of the molecular medi-
ators of the physiological stress response from colectomy.
The complexity results from the comprehensive network of
cytokines and endocrine mediators that either directly or
indirectly impact nitric oxide homeostasis and endothelial
function, and the overall inﬂammatory responses to colec-
tomy [1]. Therefore, investigation of these mediators as
stress markers can be crucial for both pre- and postoperative
risk assessment in colectomy patients. Adiponectin, resistin,
and circulating soluble receptor for advanced glycation end
products (sRAGE) (Figure 1) are among those inﬂammatory
and metabolic mediators that may impact preoperative risk
assessment and oxidative stress due to surgical trauma.2 Mediators of Inﬂammation
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Figure 1: Adiponectin, resistin, and sRAGE as inﬂammatory/metabolic mediators in human cells.
Adiponectin is an adipocyte-derived hormone which is
secreted into circulating blood and regulates systemic meta-
bolism. Adiponectin has been shown to improve whole-
body insulin sensitivity in animal models and diet-induced
obesity [2–4]. It stimulates fatty acid oxidation and glucose
uptake in skeletal muscle by increasing peripheral insulin
sensitivity [5]. Few studies have looked at adiponectin as a
potential acute-phase mediator after surgery, which would
be important as it also regulates biological processes such as
apoptosis, proliferation, migration, and inﬂammation [6].
Resistin was originally reported in a murine model as an
adipose-tissue-speciﬁc hormone.Furtherstudieshaveshown
that in humans the majority of resistin is derived from
macrophages (nonfat stroma fraction of adipose tissue) and,
to a lesser extent, from adipocytes, which explain various
results in relation to insulin resistance in mouse and human
[7, 8]. Resistin promotes a proinﬂammatory response by
modulating nuclear factor kappa-light-chain-enhancer of
activated B cells (NF-κB). A recent study has shown resistin
as a marker for acute inﬂammatory response and possibly
a prognostic marker in non-sepsis critically ill patients.
Correlation was found between HOMA-IR (homeostasis
model assessment of insulin resistance) and resistin [9].
Thus,resistinplaysanimportantroleininﬂammation aswell
as insulin resistance.
RAGE or receptor for advanced glycation end products
is a multi-ligand receptor that binds to various proteins of
diﬀerent structures. Its promoter contains multiple tran-
scriptional factor-binding sites, such as for NF-κBa n do t h e r
pro-inﬂammatory genes [10]. sRAGE is a circulating soluble
isoform of RAGE, and by competing with RAGE for ligand
b i n d i n g( a c ta sad e c o y ) ,i tm a yn e u t r a l i z eR A G E - m e d i a t e d
damage [11]. sRAGE levels have been found to be decreased
in several chronic inﬂammatory diseases [12]h o w e v e ri t s
role as an important marker for inﬂammatory response dur-
ing colectomy has not been explored.
In the last 20 years, progress has been made in reducing
various complications related to colectomy by standardizing
processes of care. Minimal invasive surgery and enhanced
recovery programs (ERPs) have played major roles in this
transition. Laparoscopy has been shown to decrease length
of stay and quicken recovery in colectomy patients, in
association with decreased responses in acute inﬂammatory
phase proteins (e.g., CRP and IL-6) [13, 14]. These beneﬁts
have been related to less direct stress with smaller wounds
and less bowel manipulation. ERP has revolutionized care
in colon and rectal surgery. The traditional programs of
colorectal operative care have been challenged with success-
ful implementation of ERP without increase in short term
morbidity [15, 16]. Although a variety of inﬂammatory and
metabolic mediators have been assessed in laparoscopic and
open colectomy patients the speciﬁc mediators used in this
study have yet to be studied. In addition, there is little
assessment of the impact of enhanced recovery program
(ERP) programs on these mediators. In this study, we
evaluated the patterns of adiponectin, resistin, and sRAGE in
patients sera at pre-operative day (PREOP), post-operative
day 1(POD1)and 3 (POD3)with laparoscopic(LAP),hand-
assisted laparoscopic surgery (HALS), or open colectomy
(OPEN), and with or without ERP, to determine their
potentials as stress markers during colectomy.
2.Materialsand Methods
2.1. Patients and Samples Collection. Serum samples for
44 colectomy patients were collected at three time points:Mediators of Inﬂammation 3
pre-operative (PREOP), postoperative day 1 (POD1), and
post-operative day 3 (POD3). Whole blood was collected in
5mL EDTA vials, centrifuged at 3,000rpm for 10 minutes,
and serum was aliquoted and stored at −80◦C. All patients
were chosen randomly and were blinded to the investigators.
Age, gender, body mass index (BMI), anesthesia risk (ASA),
operatingtime,andestimatedbloodloss(EBL)werealsocol-
lected.Inaddition, patientswere categorized into2groups—
compliance or non-compliance with ERP. Noncompliance
ERP was deﬁned as i.v. narcotic use lasting more than 48
hours after procedure without other complicating factors
of hospital stay. Each participant gave their consent, and
this study was approved by the Institutional Review Board
committee.
2.2. ELISA Assays. Serum adiponectin, resistin, or sRAGE
levels were determined by enzyme-linked immuno-absorb-
ent assay (ELISA) according to the manufacturer’s protocols
(BioVendor LLC, Candler, NC, USA). The sensitivity of each
assay was 1ng/mL, 1ng/mL and 100pg/mL, respectively.
Each sample analysis was performed in duplicates.
2.3. Statistical Analysis. Data analysis was performed using
SSPS windows version 13.0 software (SPSS Inc. Chicago, Ill,
USA). Repeated measures ANOVA were used to compare
adiponectin, resistin, and sRAGE values between days, oper-
ative techniques, and compliance or noncompliance with
ERP. P values < 0.05 were considered statistically signiﬁ-
cant.
3.Results
We collected serum samples from 22 LAP, 13 HALS, and 9
OPEN patients, with or without ERP. There were 26 males
and 18 females, and the mean age was 59.7 ± 13.5y e a r s .
Mean length of stay was 5.3 ± 1.9 days. The most common
operation was segmental colectomy (n = 33; 75%). Clinical
features of the colectomy patients are shown in Table 1.A
total of 132 (44 × 3) patient’s blood samples from PREOP,
POD1, and POD3 were used for ELISA assays.
O Rt i m e ,B M I ,A S A ,E B L ,a n dg e n d e rd i dn o ta ﬀect
the values of adiponectin, resistin, and sRAGE. During
the investigation period, adiponectin levels were signiﬁ-
cantly decreased between PREOP and POD3 (P<0.001)
(Figure 2(a)). The serum concentrations of resistin were
signiﬁcantly increased from PREOP to POD1 and reached
baseline value by POD3 (P<0.001) (Figure 2(b)). Average
resistin value was higher in patients 75 years of age and older
(26.9 versus 19.9μg/mL) (P<0.001).
There was no signiﬁcant diﬀerence of both adiponectin
and resistin levels among patients with LAP versus HAL
versus OPEN (Figures 3(a) and 3(b).H o w e v e r ,t h es e r u m
sRAGE levels were signiﬁcantly higher in LAP procedure
in comparison with HALS (P = 0.004) and OPEN (P<
0.001) (Figure 3(c)). sRAGE levels were also signiﬁcantly
higher in sera of patients that underwent ERP (P<0.001)
(Figure 4(c)).
Table 1: Clinical data of colectomy patients.
Characteristics LAP
(n = 22)
HALS
(n = 13)
OPEN
(n = 9)
Age (year, mean ± SD) 64.3 ± 12.6 56.8 ± 13.2 52.4 ± 13.1
Gender
Male 17 4 5
F e m a l e 51 14
ERP
Yes 19 9 0
N o 349
BMI
≤30 18 8 4
>3 0 455
OR time
≥3 h o u r s 823
<3 hours 14 11 6
ASA
>2 632
≤21 6 1 1 7
EBL
≥300cc 1 1 4
<300cc 21 12 5
Lap, laparoscopic; HALS, hand-assisted laparoscopic; OPEN, open colec-
tomy; ERP, enhanced recovery program; BMI, body mass index; OR, opera-
tion room; ASA, AmericanSocietyof Anesthesiologistsanesthesia risk;EBL,
estimated blood loss.
4.Discussionand Conclusions
Inﬂammatory/endocrine cytokines and mediators can have
various eﬀects on cellular function through a cascade of
pathwaysthateﬀectoxidativestressandendothelialfunction.
This cascade may lead to organ dysfunction that can be
detectablethroughphysiologicchangesrelatedtoknowndis-
ease entities like the metabolic syndrome, arthritic, diseases
and cardiovascular disorders. Some mediators/cytokines
m a yb ep r o t e c t i v e( I L - 1 0 ,I L - 4 ,a d i p o n e c t i n )w h i l eo t h e r s
have more detrimental eﬀects (IL-1, TNF-α,I L - 6 ) .T h u s ,
elucidating cytokine and mediator responses before, during,
andaftersurgicalproceduresmaypointtopredictorsforpre-
and postoperative risk in colectomy patients.
Adiponectin has been known as an important regulator
for glucose metabolism, as well as having protective anti-
inﬂammatory properties. In our study, serum adiponectin
levels decreased signiﬁcantly from PREOP to POD3. During
colectomy, reducing level of adiponectin may result in a
systemic response which increases the synthesis of proin-
ﬂammatory cytokines. Thus, adiponectin can be a marker
indicative of a signiﬁcant degree of surgical trauma. On
the other hand, adiponectin levels have been reported to
correlate inversely with insulin resistance [17]. The potential
exists that the decreasing adiponectin levels (PREOP to
POD3) observed in this study could be related to the fre-
quently identiﬁed postoperative insulin-resistance-induced
hyperglycemia in colectomy patients. It will be interesting4 Mediators of Inﬂammation
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Figure 2: Mean values of serum adiponectin, resistin, and sRAGE
concentrations.PREOP, preoperative day; POD1, postoperative day
1; POD3, postoperative day 3.
to investigate the serum adiponectin levels of hyperglycemic
colectomy patients to assess serum adiponectin’s potential as
a predictor of progression to insulin resistance.
Critical care patients have demonstrated elevated resistin
levels, particularly in association with sepsis. These levels
showed an association with other inﬂammatory markers,
including white blood cell count, CRP, and procalcitonin,
and with the proinﬂammatory cytokines IL-6, IL-10, and
TNF-α [9]. Resistin levels have also been correlated to
hyperinsulinemia, hyperglycemia, and insulin resistance in
several studies [18–20]. Here, we showed that serum resistin
levels increased signiﬁcantly from PREOP to POD1 and
returned to baseline value in POD3 in colectomy patients.
Increased resistin levels may be an additional mechanism for
the insulin resistance and inﬂammatory response caused by
surgery.
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Figure 3: Mean values of serum adiponectin, resistin, and sRAGE.
LAP, laparoscopy; HALS, hand-assisted laparoscopy; OPEN, open
colectomy.
It has been reported that sRAGE level is downregulated
in plasma of chronic hyperglycemic patients [21]. Thus,
the initial nonsigniﬁcant decreased level of sRAGE may be
associated with the increment of insulin resistance indicated
by the adiponectin and resistin levels. On the other hand, we
found that serum sRAGE levels were signiﬁcantly higher in
patients with LAP procedure in comparison with HALS and
OPEN which may be a further explanation for the reduction
in complicationstypicallyassociated with minimally invasive
colectomy. sRAGElevelswere also signiﬁcantly higherin sera
of patients that underwent ERP. It is interesting that neither
adiponectin nor resistin levels were signiﬁcantly impacted
by operative technique (LAP, HALS, and OPEN), or by the
use of ER. It is known that sRAGE acts as an endogenous
inhibitor of RAGE, neutralizing RAGE-mediating damages
by decreasing the expression of matrix metalloproteinases
and proinﬂammatory cytokinesTNF-αandIL-6[22].There-
fore, sRAGE is capable of promoting a protective role againstMediators of Inﬂammation 5
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Figure 4: Mean values of serum adiponectin, resistin, and sRAGE.
the development of inﬂammation. Higher sRAGE levels
which provide higher protection against inﬂammation may
explain the faster perioperative recovery of laparoscopic and
ERP patients undergoing colectomy. Thus, sRAGE capacity
as a marker for inﬂammatory stress response and its protec-
tive mechanism warrants further investigation.
This is a proof-of-concept study to suggest that inﬂam-
matory and metabolic mediators can be evaluated as poten-
tial physiological biomarkers related to surgical stress in
c o l e c t o m yp a t i e n t s .H e r e ,w eh a v ed e m o n s t r a t e dt h a ts e r u m
adiponectin, resistin, and sRAGE have the potential of devel-
oping into a panel of operative stress markers for inﬂamma-
tory response in colectomy patients. Further experimental
and clinical studies are required to establish the role of
adiponectin and resistin as predictors for insulin resistance
progression that is commonly related to surgical compli-
cations. Comprehensive and validation studies on other
inﬂammatory and metabolicmediators,besidesadiponectin,
resistin, andsRAGEpresentedinthisstudy,willleadtobetter
understanding of the complex immunologic and metabolic
responses in colectomy patients which will facilitate risk
assessment and improve colectomy management and out-
come.
What IsNew in ThisPaper?
This is the ﬁrst report that describes the potential of serum
adiponectin, resistin, and sRAGE as stress markers for surgi-
cal trauma. This is the ﬁrst paper to indicate higher serum
sRAGE levels in association with laparoscopic colectomy and
ERP patients.
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